THE ABILITY OF TORASEMIDE FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Torasemide - loop diuretic has high favorable pharmacodynamic properties. The article presents data on the clinical efficacy of torasemide in patients with chronic heart failure, arterial hypertension and patients with cirrhosis and ascites.

Full Text

Restricted Access

About the authors

Mikhail Yevgenevich Statsenko

Volgograd State Medical University

Email: mestatsenko@rambler.ru

Svetlana Vladimirovna Turkina

Volgograd State Medical University

Email: turkinasv@rambler.ru

References

  1. Cosin J., Diez J. and TORIC investigators. Torasemide in chronic heart failure: results of the TORIC study//Eur. J. Heart Fail.-2002. -4 (4). -507-13.
  2. Lopez B., Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. Journal of the American College of Cardiology Vol. 43. No. 11, 2004;2028-35.
  3. Мареев В.Ю., Агеев Ф.Т., Арутюнов Г.П., Коротеев А. В., Мареев Ю. В., Овчинников А. Г., Беленков Ю. Н., Васюк Ю. А., Галявич А. С., Гарганеева А. А., Гиляревский С. Р., Глезер М. Г., Драпкина О. М., Козиолова Н. А., Коц Я. И., Лопатин Ю. М., Мартынов А. И., Моисеев В. С., Ревишвили А. Ш., Ситникова М. Ю., Скибицкий В. В., Соколов Е. И., Сторожаков Г. И., Фомин И. В., Чесникова А. И., Шляхто Е. В. Национальные рекомендации ОССН, РКО и РНМОТ по диагностике и лечению ХСН (4-й пересмотр). Сердечная недостаточность. 2013;7:379-472
  4. Stauch M., Stiehl M. Controlled double blind clinical trial on the efficacy and tolerance of torasemide in patients with congestive heart failure. A multi-center study. In: Progress in Pharmacology and Clinical Pharmacology. Gustav-Fischer-Verlag Stuttgart. 1990;8:121-6.
  5. Noe L.L., Vreeland M.G., Pezzella S.M., Trotter J.P. A pharmaeco-nomical assessment of torasemide and furosemide in the treatment of patients with congestive heart failure. Clin. Ther. 1999;21:854-60.
  6. Cosin J., Diez J. TORIC investigators. Torasemide in chronic heart failure: results of the TORIC study. Eur. J. Heart Fail. 2002;4:507-13.
  7. Murray M.D., Deer M.M., Ferguson J.A., Dexter P.R., Bennett S.J., Perkins S.M., Smith F.E., Lane K.A., Adams L.D., Tierney W.M., Brater D.C. Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am. J. Med. 2001 ;111(7):513-20.
  8. Friedel H.A., Buckley M.M. Torasemide. A review of its pharmacological properties and therapeutic potential. Drugs. 1991 ;41 (1 ):81 -103.
  9. Мареев В.Ю., Выгодин В.А., Беленков Ю.Н. Диуретическая терапия Эффективными дозами перораЛЬных диуретиков торасемида (Диувер) и фуросемида в лечении больных с обострением Хронической Сердечной Недостаточности (ДУЭЛЬ-ХСН). Сердечная недостаточность. 2011;1:3-10
  10. Kasama S., Toyama T., Hatori T., Sumino H., Kumakura H., Takayama Y., Ichikawa S., Suzuki T., Kurabayashi M. Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure. Heart. 2006;92(10):1434-
  11. Агеев Ф.Т., Жубрина Е.С., Гиляревский С.Р., Мареев В.Ю., Хосева Е.Н., Голшмид М.В., Деев А.Д., Коткина Т.И., Лукина Ю.В., Малишевский М.В., Масенко В.П., Рогожкина Ю.А., Середенина Е.М., Синицина И.И., Сусликов А.В., Титов В.Н. Сравнительная эффективность и безопасность длительного применения торасемида и фуросемида у больных с компенсированной сердечной недостаточностью. Влияние на маркеры фиброза миокарда. Сердечная недостаточность. 2013;14(2):3-8
  12. Lopez B, Querejrta R, Gonzalez A., Sanchez E., Larman M., Diez J. Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. J. Am. Coll. Cardiol. 2004;43(11):2028-35.
  13. Veeraveedu P.T., Watanabe K., Ma M., Thandavarayan R.A., Palaniyandi S.S., Yamaguchi K., Suzuki K., Kodama M., Aizawa Y. Comparative effects of torasemide and furosemide in rats with heart failure. Biochem. Pharmacol. 2007;23:143-8.
  14. Uchida T., Yamanaga K., Nishikawa M., Ohtaki Y., Kido H., Watanabe M. Antialdosteronergic effect of torasemide. Eur. J. Pharmacol. 1991 ;205(2) :145-50.
  15. Tsutamoto T., Sakai H., Wada A., Ishikawa C., Ohno K., Fujii M., Yamamoto T., Takayama T., Dohke T., Horie M. Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure. J. Am. Coll. Cardiol. 2004;44(11):2252-3.
  16. Spannbrucker N., Achhammer I., Metz P., Glocke M. Comparative study on the hypertensive efficacy of torasemide and indapamide in patiehts with essential hypertension. Drug Res. 1988;38:1:190-3.
  17. Achhammer I., Metz P. Low dose loop diuretics in essential hypertension. Experience with torasemide. Drugs. 1991 ;41 (Suppl 3):80-91.
  18. Baumgart P. Torasemide in comparison with thiazides in the treatment of hypertension. Cardiovasc. Drug Ther. 1993;7(Suppl 1):63-8.
  19. Dunn C.J., Fittion A., Broglen R.N. Torasemide. Review of its pharmacology and therapeutic use. Drugs. 1995;49:121-42.
  20. Fortuno A., Muniz P., Ravassa S., Rodriguez J.A., Fortuno M.A., Zalba G., Diez J. Torasemide inhibits angiotensin II-induced vasoconstriction and intractllular calcium increase in the aorta of spontaneously hypertensive rats. Hypertension. 1999; 34:138-43.
  21. De Berrazueta J.R., Gonzalez J.P., de Mier I., Poveda J.J., García-Unzueta M.T. Vasodilatory action of loop diuretics: A plethysmography study of endothelial function in forearm arteries and dorsal hand veins in hypertensive patients and controls.J. Cardiovasc. Pharmacol. 2007;49:90-5.
  22. Brunner G., Estrada E., Plesche L. Efficacy and safety of to-rasemide (5 to 40 mg o. d.) in the treatment of oedema in patients with hydrppically decompensated liver failure. Diuretics IV: Chemistry, Pharmacology and clinical Applications. Amsterdam: Excerpta Medica. 1993;4:27-30.
  23. Gentilini P., Laffi G., La Villa G., Carloni V., Foschi M., Romanelli R.G., Marra F. Torasemide in the treatment of patients with cirrhosis and ascites. Cardiovasc. Drugs Ther. 1993;7(Suppl 1 ) :81 -5.
  24. Gentilini P., La Villa G., Marra F., Carloni V., Melani L., Foschi M., Cotrozzi G., Quartini M., Chibbaro G., Tommasi A.C., Bernareggi A., Simoni A., Buzzelli G., Laffi G. Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. J. Hepatol. 1996;25(4):481-90.
  25. Fiaccadori F., Pedretti G., Pasetti G., Pizzaferri P., Elia G. Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study. Clin. I nvest.1993;71 (7):579-84.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies